Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Self-treatment of Painful Diabetic Neuropathy Using Electrical Vasomotor Nerve Stimulation

NCT06524284 is registered in ClinicalTrials.gov with Neurecon BV as lead sponsor.

NCT NCT06524284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06524284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Self-treatment of Painful Diabetic Neuropathy Using Electrical Vasomotor Nerve Stimulation
Lead sponsor
Neurecon BV
Phase
Not applicable
Overall status
Completed
Start date
July 22, 2024
Completion date
March 30, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

painful diabetic neuropathy